L-Carnosine for Bipolar I Disorder
A Pilot Add-on Randomized, Placebo Controlled Intervention Trial of Cognitive Enhancement in Persons With Bipolar Disorder Using an Antioxidant and Advanced Glycation End (AGE) Product Inhibitor: L-Carnosine
Sponsor: National Alliance for Research on Schizophrenia and Depression
A NA clinical study on Bipolar I Disorder, this trial is completed. The trial is conducted by National Alliance for Research on Schizophrenia and Depression and has accumulated 6 data snapshots since 2004. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Alliance for Research on Schizophrenia and Depression
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .